Loading...
XSHE002923
Market cap430mUSD
Jan 09, Last price  
9.42CNY
1D
-3.19%
1Q
3.06%
IPO
14.55%
Name

Zhuhai Rundu Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:002923 chart
P/E
47.16
P/S
2.44
EPS
0.20
Div Yield, %
3.25%
Shrs. gr., 5y
0.30%
Rev. gr., 5y
4.36%
Revenues
1.29b
-5.86%
311,179,689361,933,893434,131,304523,598,200577,942,780651,862,100779,421,0161,043,860,4651,359,908,2951,252,630,8361,189,926,8671,372,233,9171,291,887,142
Net income
67m
-56.97%
32,211,69356,596,22859,359,21359,519,86071,165,38287,465,79890,652,611106,844,362118,896,727135,862,411139,766,332155,476,93666,898,617
CFO
173m
+27.90%
33,710,09170,013,89831,674,10058,011,47650,138,96794,069,92257,952,639159,043,847151,299,880250,346,177205,906,013135,007,685172,679,270
Dividend
May 31, 20240.2 CNY/sh
Earnings
May 16, 2025

Profile

Zhuhai Rundu Pharmaceutical Co., Ltd., a pharmaceutical company, develops, produces, and markets pharmaceutical ingredients for cardiovascular, gastrointestinal, CNS, and anesthesia areas in China and internationally. It offers APIs, intermediates, FDF, and pellets, as well as formulations in the forms of capsules, tablets, and injections. The company was founded in 1997 and is headquartered in Zhuhai, China.
URL
http://www.rdpharma.cn/
IPO date
Jan 05, 2018
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,291,887
-5.86%
1,372,234
15.32%
Cost of revenue
1,206,981
1,109,531
Unusual Expense (Income)
NOPBT
84,906
262,703
NOPBT Margin
6.57%
19.14%
Operating Taxes
19,141
25,462
Tax Rate
22.54%
9.69%
NOPAT
65,765
237,240
Net income
66,899
-56.97%
155,477
11.24%
Dividends
(102,381)
(74,272)
Dividend yield
2.48%
1.77%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
60,541
89,966
Long-term debt
448,830
379,436
Deferred revenue
157,571
120,985
Other long-term liabilities
1,072
1,178
Net debt
294,959
247,871
Cash flow
Cash from operating activities
172,679
135,008
CAPEX
(174,534)
Cash from investing activities
(174,534)
Cash from financing activities
(4,480)
73,200
FCF
(14,545)
(68,883)
Balance
Cash
213,912
221,093
Long term investments
500
438
Excess cash
149,817
152,920
Stockholders' equity
865,677
917,119
Invested Capital
1,689,877
1,603,711
ROIC
3.99%
16.23%
ROCE
4.61%
14.95%
EV
Common stock shares outstanding
334,493
334,873
Price
12.34
-1.28%
12.50
-7.18%
Market cap
4,127,645
-1.39%
4,185,916
-7.13%
EV
4,422,604
4,433,786
EBITDA
197,773
334,930
EV/EBITDA
22.36
13.24
Interest
17,237
6,966
Interest/NOPBT
20.30%
2.65%